{"transactions":[{"id":723875,"issuer":{"id":6306,"kind":"organization","name":"IMMUNIC, INC."},"owners":[{"id":34789,"kind":"person","name":"Tardio Jason","position":1,"cik":"0001794698","reported_name":"Tardio Jason","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and COO"}}],"security":"Stock Option","published_at":"2026-06-29T20:31:55.000Z","date":"2026-06-29","kind":"grant","planned":false,"acquired":true,"shares":253000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents options to purchase shares of common stock conditionally approved by the Board of Directors, subject to approval of an amendment to the Company's 2019 Omnibus Equity Incentive Plan, as amended, by the Company's stockholders, which approval was obtained at the Company's 2026 Annual Meeting of Stockholders held on June 29, 2026."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares underlying this option vest 25% on April 2, 2027, and the remainder vest in equal increments on each successive one-month anniversary thereafter for the next thirty-six months."}],"balance_after":253000,"derivative":{"exercise_price":11.6,"expiration_date":"2036-04-02","underlying":"Common Stock","underlying_shares":253000},"source":{"system":"sec-edgar","filing":"0001193805-26-000886","document":"e665606_4-jason.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1280776/000119380526000886/e665606_4-jason.xml","form_type":"4"}},{"id":1084606,"issuer":{"id":6306,"kind":"organization","name":"IMMUNIC, INC."},"owners":[{"id":34789,"kind":"person","name":"Tardio Jason","position":1,"cik":"0001794698","reported_name":"Tardio Jason","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and COO"}}],"security":"Stock Appreciation Right","published_at":"2025-07-18T20:05:25.000Z","date":"2025-07-16","kind":"grant","planned":false,"acquired":true,"shares":330000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Exercisable beginning August 1, 2026, subject to the Issuer's issuance of Common Stock or pre-funded warrants to subscribers in connection with the third tranche of the January 2024 Offering."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F1","text":"The Stock Appreciation Rights (\"SARs\") could be settled for cash, but it is the intention of the Issuer that these SARs will be settled for shares of the Issuer's common stock, par value $0.0001 per share (\"Common Stock\") provided the Issuer obtains stockholder approval to amend the Issuer's 2019 Omnibus Equity Incentive Plan, as amended, to provide for a sufficient number of shares of Common Stock to support the settlement of the SARs in shares of Common Stock."}],"balance_after":330000,"derivative":{"exercise_price":0.77,"exercise_date":"2026-08-01","expiration_date":"2035-07-16","underlying":"Common Stock","underlying_shares":330000},"source":{"system":"sec-edgar","filing":"0001193805-25-001065","document":"e664705_4-jason.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1280776/000119380525001065/e664705_4-jason.xml","form_type":"4"}},{"id":1084605,"issuer":{"id":6306,"kind":"organization","name":"IMMUNIC, INC."},"owners":[{"id":34789,"kind":"person","name":"Tardio Jason","position":1,"cik":"0001794698","reported_name":"Tardio Jason","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and COO"}}],"security":"Stock Appreciation Right","published_at":"2025-07-18T20:05:25.000Z","date":"2025-07-16","kind":"grant","planned":false,"acquired":true,"shares":330000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Exercisable beginning August 1, 2026, subject to the Issuer's issuance of Common Stock or pre-funded warrants to subscribers in connection with the second tranche of the Issuer's January 4, 2024 private placement (the \"January 2024 Offering\")."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F1","text":"The Stock Appreciation Rights (\"SARs\") could be settled for cash, but it is the intention of the Issuer that these SARs will be settled for shares of the Issuer's common stock, par value $0.0001 per share (\"Common Stock\") provided the Issuer obtains stockholder approval to amend the Issuer's 2019 Omnibus Equity Incentive Plan, as amended, to provide for a sufficient number of shares of Common Stock to support the settlement of the SARs in shares of Common Stock."}],"balance_after":330000,"derivative":{"exercise_price":0.77,"exercise_date":"2026-08-01","expiration_date":"2035-07-16","underlying":"Common Stock","underlying_shares":330000},"source":{"system":"sec-edgar","filing":"0001193805-25-001065","document":"e664705_4-jason.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1280776/000119380525001065/e664705_4-jason.xml","form_type":"4"}},{"id":1084604,"issuer":{"id":6306,"kind":"organization","name":"IMMUNIC, INC."},"owners":[{"id":34789,"kind":"person","name":"Tardio Jason","position":1,"cik":"0001794698","reported_name":"Tardio Jason","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and COO"}}],"security":"Stock Appreciation Right","published_at":"2025-07-18T20:05:25.000Z","date":"2025-07-16","kind":"grant","planned":false,"acquired":true,"shares":660000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Exercisable beginning August 1, 2026, subject to the exercise of the Issuer's series B purchase warrants by the holders thereof."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F1","text":"The Stock Appreciation Rights (\"SARs\") could be settled for cash, but it is the intention of the Issuer that these SARs will be settled for shares of the Issuer's common stock, par value $0.0001 per share (\"Common Stock\") provided the Issuer obtains stockholder approval to amend the Issuer's 2019 Omnibus Equity Incentive Plan, as amended, to provide for a sufficient number of shares of Common Stock to support the settlement of the SARs in shares of Common Stock."}],"balance_after":660000,"derivative":{"exercise_price":0.77,"exercise_date":"2026-08-01","expiration_date":"2035-07-16","underlying":"Common Stock","underlying_shares":660000},"source":{"system":"sec-edgar","filing":"0001193805-25-001065","document":"e664705_4-jason.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1280776/000119380525001065/e664705_4-jason.xml","form_type":"4"}},{"id":1084603,"issuer":{"id":6306,"kind":"organization","name":"IMMUNIC, INC."},"owners":[{"id":34789,"kind":"person","name":"Tardio Jason","position":1,"cik":"0001794698","reported_name":"Tardio Jason","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and COO"}}],"security":"Stock Appreciation Right","published_at":"2025-07-18T20:05:25.000Z","date":"2025-07-16","kind":"grant","planned":false,"acquired":true,"shares":660000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Exercisable beginning August 1, 2026, subject to the exercise of the Issuer's series A purchase warrants by the holders thereof."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F1","text":"The Stock Appreciation Rights (\"SARs\") could be settled for cash, but it is the intention of the Issuer that these SARs will be settled for shares of the Issuer's common stock, par value $0.0001 per share (\"Common Stock\") provided the Issuer obtains stockholder approval to amend the Issuer's 2019 Omnibus Equity Incentive Plan, as amended, to provide for a sufficient number of shares of Common Stock to support the settlement of the SARs in shares of Common Stock."}],"balance_after":660000,"derivative":{"exercise_price":0.77,"exercise_date":"2026-08-01","expiration_date":"2035-07-16","underlying":"Common Stock","underlying_shares":660000},"source":{"system":"sec-edgar","filing":"0001193805-25-001065","document":"e664705_4-jason.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1280776/000119380525001065/e664705_4-jason.xml","form_type":"4"}},{"id":1084602,"issuer":{"id":6306,"kind":"organization","name":"IMMUNIC, INC."},"owners":[{"id":34789,"kind":"person","name":"Tardio Jason","position":1,"cik":"0001794698","reported_name":"Tardio Jason","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and COO"}}],"security":"Stock Appreciation Right","published_at":"2025-07-18T20:05:25.000Z","date":"2025-07-16","kind":"grant","planned":false,"acquired":true,"shares":330000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F1","text":"The Stock Appreciation Rights (\"SARs\") could be settled for cash, but it is the intention of the Issuer that these SARs will be settled for shares of the Issuer's common stock, par value $0.0001 per share (\"Common Stock\") provided the Issuer obtains stockholder approval to amend the Issuer's 2019 Omnibus Equity Incentive Plan, as amended, to provide for a sufficient number of shares of Common Stock to support the settlement of the SARs in shares of Common Stock."}],"balance_after":330000,"derivative":{"exercise_price":0.77,"exercise_date":"2026-08-01","expiration_date":"2035-07-16","underlying":"Common Stock","underlying_shares":330000},"source":{"system":"sec-edgar","filing":"0001193805-25-001065","document":"e664705_4-jason.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1280776/000119380525001065/e664705_4-jason.xml","form_type":"4"}},{"id":1104858,"issuer":{"id":6306,"kind":"organization","name":"IMMUNIC, INC."},"owners":[{"id":34789,"kind":"person","name":"Tardio Jason","position":1,"cik":"0001794698","reported_name":"Tardio Jason","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and COO"}}],"security":"Stock Option","published_at":"2025-06-20T21:16:19.000Z","date":"2025-06-05","kind":"grant","planned":false,"acquired":true,"shares":598500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the shares underlying the option vest on the first anniversary of the grant date, with the remainder vesting in equal increments on each successive one-month anniversary thereafter for the next 36 months."}],"balance_after":598500,"derivative":{"exercise_price":0.7729,"expiration_date":"2035-06-05","underlying":"Common Stock","underlying_shares":598500},"source":{"system":"sec-edgar","filing":"0001193805-25-000925","document":"e664640_4a-jason.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1280776/000119380525000925/e664640_4a-jason.xml","form_type":"4/A","original_submission_date":"2025-06-09"}},{"id":1104857,"issuer":{"id":6306,"kind":"organization","name":"IMMUNIC, INC."},"owners":[{"id":34789,"kind":"person","name":"Tardio Jason","position":1,"cik":"0001794698","reported_name":"Tardio Jason","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and COO"}}],"security":"Common Stock","published_at":"2025-06-20T21:16:19.000Z","date":"2025-06-05","kind":"purchase","planned":false,"acquired":true,"shares":12512,"price":0.79,"value":9884.48,"ownership":{"direct":true},"balance_after":12512,"source":{"system":"sec-edgar","filing":"0001193805-25-000925","document":"e664640_4a-jason.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1280776/000119380525000925/e664640_4a-jason.xml","form_type":"4/A","original_submission_date":"2025-06-09"}},{"id":1117691,"issuer":{"id":6306,"kind":"organization","name":"IMMUNIC, INC."},"owners":[{"id":34789,"kind":"person","name":"Tardio Jason","position":1,"cik":"0001794698","reported_name":"Tardio Jason","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and COO"}}],"security":"Stock Option","published_at":"2025-06-09T20:07:31.000Z","date":"2025-06-05","kind":"grant","planned":false,"acquired":true,"shares":595000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the shares underlying the option vest on the first anniversary of the grant date, with the remainder vesting in equal increments on each successive one-month anniversary thereafter for the next 36 months."}],"balance_after":595000,"derivative":{"exercise_price":0.7729,"expiration_date":"2035-06-05","underlying":"Common Stock","underlying_shares":595000},"source":{"system":"sec-edgar","filing":"0001193805-25-000839","document":"e664608_4-jason.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1280776/000119380525000839/e664608_4-jason.xml","form_type":"4"}},{"id":1117690,"issuer":{"id":6306,"kind":"organization","name":"IMMUNIC, INC."},"owners":[{"id":34789,"kind":"person","name":"Tardio Jason","position":1,"cik":"0001794698","reported_name":"Tardio Jason","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and COO"}}],"security":"Common Stock","published_at":"2025-06-09T20:07:31.000Z","date":"2025-06-05","kind":"purchase","planned":false,"acquired":true,"shares":12512,"price":0.79,"value":9884.48,"ownership":{"direct":true},"balance_after":12512,"source":{"system":"sec-edgar","filing":"0001193805-25-000839","document":"e664608_4-jason.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1280776/000119380525000839/e664608_4-jason.xml","form_type":"4"}},{"id":1340267,"issuer":{"id":6306,"kind":"organization","name":"IMMUNIC, INC."},"owners":[{"id":34789,"kind":"person","name":"Tardio Jason","position":1,"cik":"0001794698","reported_name":"Tardio Jason","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and COO"}}],"security":"Stock Option","published_at":"2024-12-06T22:31:19.000Z","date":"2024-12-04","kind":"grant","planned":false,"acquired":true,"shares":157500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the shares underlying the option vest on the first anniversary of the grant date, with the remainder vesting in equal increments on each successive one-month anniversary thereafter for the next 36 months."}],"balance_after":157500,"derivative":{"exercise_price":1.25,"expiration_date":"2034-12-04","underlying":"Common Stock","underlying_shares":157500},"source":{"system":"sec-edgar","filing":"0001193805-24-001442","document":"e664060_4-jason.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1280776/000119380524001442/e664060_4-jason.xml","form_type":"4"}},{"id":1455234,"issuer":{"id":6306,"kind":"organization","name":"IMMUNIC, INC."},"owners":[{"id":34789,"kind":"person","name":"Tardio Jason","position":1,"cik":"0001794698","reported_name":"Tardio Jason","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and COO"}}],"security":"Stock Option","published_at":"2024-07-12T12:31:36.000Z","date":"2024-07-12","kind":"grant","planned":false,"acquired":true,"shares":500000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options disclosed on this Form 4 are time vested; 25 percent of the shares underlying the options awarded to the Reporting Person will vest on July 12, 2025, and 75 percent of them will vest in 36 equal monthly installments, subject to the Reporting Person remaining an employee of Immunic, Inc. in good standing through the relevant vesting date."}],"balance_after":500000,"derivative":{"exercise_price":1.25,"expiration_date":"2034-07-12","underlying":"Common Stock","underlying_shares":500000},"source":{"system":"sec-edgar","filing":"0001193805-24-000914","document":"e663770_4-jason.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1280776/000119380524000914/e663770_4-jason.xml","form_type":"4"}},{"id":1618588,"issuer":{"id":5411,"kind":"organization","name":"Ovid Therapeutics Inc."},"owners":[{"id":34789,"kind":"person","name":"Tardio Jason","position":1,"cik":"0001794698","reported_name":"Tardio Jason","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-02-26T23:05:11.000Z","date":"2024-02-22","kind":"grant","planned":false,"acquired":true,"shares":168750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"25% of the shares subject to the Stock Option will vest and become exercisable on February 22, 2025 and the remaining shares will vest in 36 equal monthly installments thereafter, subject to the Reporting Person's continued services through such date."}],"balance_after":168750,"derivative":{"exercise_price":3.68,"expiration_date":"2034-02-21","underlying":"Common Stock","underlying_shares":168750},"source":{"system":"sec-edgar","filing":"0001209191-24-003972","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1636651/000120919124003972/doc4.xml","form_type":"4"}},{"id":1618587,"issuer":{"id":5411,"kind":"organization","name":"Ovid Therapeutics Inc."},"owners":[{"id":34789,"kind":"person","name":"Tardio Jason","position":1,"cik":"0001794698","reported_name":"Tardio Jason","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2024-02-26T23:05:11.000Z","date":"2024-02-22","kind":"grant","planned":false,"acquired":true,"shares":28125,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents a restricted stock unit (RSU) award. One-third (1/3) of the total number of RSUs shall vest on January 1, 2025 and one-third (1/3) of the remaining RSUs shall vest each year thereafter on anniversary of the vesting commencement date, subject to the Reporting Person's continuous service through such vesting date."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each RSU represents a contingent right to receive one share of Common Stock."}],"balance_after":28125,"source":{"system":"sec-edgar","filing":"0001209191-24-003972","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1636651/000120919124003972/doc4.xml","form_type":"4"}},{"id":1989610,"issuer":{"id":5411,"kind":"organization","name":"Ovid Therapeutics Inc."},"owners":[{"id":34789,"kind":"person","name":"Tardio Jason","position":1,"cik":"0001794698","reported_name":"Tardio Jason","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-02-27T22:27:44.000Z","date":"2023-02-23","kind":"grant","acquired":true,"shares":175000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the shares subject to the Stock Option will vest and become exercisable on February 23, 2024 and the remaining shares will vest in 36 equal monthly installments thereafter subject to the Reporting Person's continued services through such date."}],"balance_after":175000,"derivative":{"exercise_price":2.5,"expiration_date":"2033-02-22","underlying":"Common Stock","underlying_shares":175000},"source":{"system":"sec-edgar","filing":"0001209191-23-013309","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1636651/000120919123013309/doc4.xml","form_type":"4"}},{"id":2159108,"issuer":{"id":5411,"kind":"organization","name":"Ovid Therapeutics Inc."},"owners":[{"id":34789,"kind":"person","name":"Tardio Jason","position":1,"cik":"0001794698","reported_name":"Tardio Jason","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2022-09-14T20:58:34.000Z","date":"2022-09-12","kind":"sale","acquired":false,"shares":17344,"price":2.15,"value":37289.6,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The Reporting Person acquired the shares pursuant to the Issuer's employee stock purchase plan. These transactions were exempt under both Rule 16b-3(d) and Rule 16b-3(c). Following the reported transaction, the Reporting Person will hold no ESPP shares."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"The Reporting Person acquired the shares pursuant to the Issuer's employee stock purchase plan. These transactions were exempt under both Rule 16b-3(d) and Rule 16b-3(c). Following the reported transaction, the Reporting Person will hold no ESPP shares."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001209191-22-049938","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1636651/000120919122049938/doc4.xml","form_type":"4"}},{"id":2298185,"issuer":{"id":5411,"kind":"organization","name":"Ovid Therapeutics Inc."},"owners":[{"id":34789,"kind":"person","name":"Tardio Jason","position":1,"cik":"0001794698","reported_name":"Tardio Jason","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-04-12T21:40:44.000Z","date":"2022-04-08","kind":"grant","acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option shall vest as follows: 25% of the shares subject to the option will vest and become exercisable on April 8, 2023 and the remaining shares will vest in 36 equal monthly installments thereafter, subject to the Reporting Person's continuous services through such vesting date."}],"balance_after":10000,"derivative":{"exercise_price":3.22,"expiration_date":"2023-04-07","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001209191-22-024191","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1636651/000120919122024191/doc4.xml","form_type":"4"}},{"id":2298184,"issuer":{"id":5411,"kind":"organization","name":"Ovid Therapeutics Inc."},"owners":[{"id":34789,"kind":"person","name":"Tardio Jason","position":1,"cik":"0001794698","reported_name":"Tardio Jason","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-04-12T21:40:44.000Z","date":"2022-04-08","kind":"grant","acquired":true,"shares":87498,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option shall vest as follows: 25% of the shares subject to the option will vest and become exercisable October 8, 2022 and the remaining shares will vest in 18 equal monthly installments thereafter, subject to the Reporting Person's continuous service through such vesting date."}],"balance_after":87498,"derivative":{"exercise_price":3.22,"expiration_date":"2023-04-07","underlying":"Common Stock","underlying_shares":87498},"source":{"system":"sec-edgar","filing":"0001209191-22-024191","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1636651/000120919122024191/doc4.xml","form_type":"4"}},{"id":2411321,"issuer":{"id":5411,"kind":"organization","name":"Ovid Therapeutics Inc."},"owners":[{"id":34789,"kind":"person","name":"Tardio Jason","position":1,"cik":"0001794698","reported_name":"Tardio Jason","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-02-04T23:24:13.000Z","date":"2022-02-03","kind":"grant","acquired":true,"shares":175000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the shares subject to the Stock Option will vest and become exercisable on February 3, 2023 and the remaining shares will vest in 36 equal monthly installments thereafter subject to the Reporting Person's continued services through such date."}],"balance_after":175000,"derivative":{"exercise_price":2.72,"expiration_date":"2032-02-02","underlying":"Common Stock","underlying_shares":175000},"source":{"system":"sec-edgar","filing":"0001209191-22-007314","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1636651/000120919122007314/doc4.xml","form_type":"4"}},{"id":2647095,"issuer":{"id":5411,"kind":"organization","name":"Ovid Therapeutics Inc."},"owners":[{"id":34789,"kind":"person","name":"Tardio Jason","position":1,"cik":"0001794698","reported_name":"Tardio Jason","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-07-01T20:23:36.000Z","date":"2021-07-01","kind":"grant","acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the shares subject to the Stock Option will vest and become exercisable on July 1, 2022 and the remaining shares will vest in 36 equal monthly installments thereafter subject to the Reporting Person's continued services through such date."}],"balance_after":50000,"derivative":{"exercise_price":3.95,"expiration_date":"2031-06-30","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001209191-21-044391","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1636651/000120919121044391/doc4.xml","form_type":"4"}},{"id":2735484,"issuer":{"id":5411,"kind":"organization","name":"Ovid Therapeutics Inc."},"owners":[{"id":34789,"kind":"person","name":"Tardio Jason","position":1,"cik":"0001794698","reported_name":"Tardio Jason","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-04-29T21:30:56.000Z","date":"2020-11-25","kind":"grant","acquired":true,"shares":44000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"On May 5, 2020, the Reporting Person was granted the option to purchase shares of the Issuer's common stock, subject to a performance-based vesting condition to be satisfied upon the achievement of a particular milestone related to the Issuer's clinical trial, and further subject to the Reporting Person's continuous service through such vesting date. Such option vested in full on November 25, 2020 upon the satisfaction of such performance-based vesting condition."}],"balance_after":44000,"derivative":{"exercise_price":3.66,"exercise_date":"2020-11-25","expiration_date":"2030-05-04","underlying":"Common Stock","underlying_shares":44000},"source":{"system":"sec-edgar","filing":"0001209191-21-029041","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1636651/000120919121029041/doc4.xml","form_type":"4"}},{"id":2874006,"issuer":{"id":5411,"kind":"organization","name":"Ovid Therapeutics Inc."},"owners":[{"id":34789,"kind":"person","name":"Tardio Jason","position":1,"cik":"0001794698","reported_name":"Tardio Jason","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-02-09T01:27:44.000Z","date":"2021-02-05","kind":"grant","acquired":true,"shares":75000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"On June 19, 2020, the reporting person was granted an option for 175,000 shares of common stock. The option vests in three tranches based on the satisfaction of certain performance criteria. The performance criteria for the second tranche was met and approved on 2/5/2021, resulting in the vesting of 75,000 shares."}],"balance_after":75000,"derivative":{"exercise_price":7.4,"exercise_date":"2021-02-05","expiration_date":"2030-06-19","underlying":"Common Stock","underlying_shares":75000},"source":{"system":"sec-edgar","filing":"0001209191-21-008642","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1636651/000120919121008642/doc4.xml","form_type":"4"}},{"id":2935776,"issuer":{"id":5411,"kind":"organization","name":"Ovid Therapeutics Inc."},"owners":[{"id":34789,"kind":"person","name":"Tardio Jason","position":1,"cik":"0001794698","reported_name":"Tardio Jason","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2020-12-21T22:08:29.000Z","date":"2020-12-17","kind":"grant","acquired":true,"shares":175000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the shares subject to the Stock Option will vest and become exercisable on December 17, 2021 and the remaining shares will vest in 36 equal monthly installments thereafter subject to the Reporting Person's continued services through such date."}],"balance_after":175000,"derivative":{"exercise_price":2.82,"expiration_date":"2030-12-16","underlying":"Common Stock","underlying_shares":175000},"source":{"system":"sec-edgar","filing":"0001209191-20-064678","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1636651/000120919120064678/doc4.xml","form_type":"4"}},{"id":3101517,"issuer":{"id":5411,"kind":"organization","name":"Ovid Therapeutics Inc."},"owners":[{"id":34789,"kind":"person","name":"Tardio Jason","position":1,"cik":"0001794698","reported_name":"Tardio Jason","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2020-06-23T20:33:45.000Z","date":"2020-06-19","kind":"grant","acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"On June 19, 2020, the reporting person was granted an option for 175,000 shares of common stock. The option vests in three tranches based on the satisfaction of certain performance criteria. The performance criteria for the first tranche was met on the date of grant, resulting in the vesting of 50,000 shares."}],"balance_after":50000,"derivative":{"exercise_price":7.4,"exercise_date":"2020-06-19","expiration_date":"2030-06-18","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001209191-20-038475","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1636651/000120919120038475/doc4.xml","form_type":"4"}},{"id":3362591,"issuer":{"id":5411,"kind":"organization","name":"Ovid Therapeutics Inc."},"owners":[{"id":34789,"kind":"person","name":"Tardio Jason","position":1,"cik":"0001794698","reported_name":"Tardio Jason","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2019-11-21T13:59:10.000Z","date":"2019-11-18","kind":"grant","acquired":true,"shares":125000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the shares subject to the Stock Option will vest and become exercisable on November 18, 2020 and the remaining shares will vest in 36 equal monthly installments thereafter subject to the Reporting Person's continued services through such date."}],"balance_after":125000,"derivative":{"exercise_price":2.76,"expiration_date":"2029-11-17","underlying":"Common Stock","underlying_shares":125000},"source":{"system":"sec-edgar","filing":"0001209191-19-057557","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1636651/000120919119057557/doc4.xml","form_type":"4"}}]}